Unit 1: Molecules, Diet, Transport and Health

Water is polar: oxygen attracts the shared electrons more strongly than hydrogen, giving oxygen a partial negative charge and hydrogen a partial positive charge. This lets water molecules form hydrogen bonds with one another and with other polar substances.

Water dissolves ions and other polar molecules, so blood plasma and plant sap can carry solutes. Its cohesion helps maintain continuous water columns, while its high specific heat capacity makes temperature changes less abrupt.

Sodium ions do not travel as isolated crystals in plasma; they are surrounded by oriented water molecules. In xylem, hydrogen bonding between water molecules helps a transpiration stream remain continuous when evaporation pulls water upwards.

Water is not a universal solvent: non-polar lipids do not dissolve readily. Polarity explains both transport of charged solutes and why membranes can separate aqueous compartments.

Monosaccharides are single sugars such as glucose, fructose and galactose. A disaccharide contains two monosaccharides joined by a glycosidic bond; a polysaccharide is a long chain of sugar units.

Maltose is glucose–glucose, sucrose is glucose–fructose and lactose is glucose–galactose. Starch contains amylose and branched amylopectin; glycogen is even more highly branched, making glucose release faster in animal cells.

Small sugars are soluble and readily transported, whereas starch and glycogen are compact, insoluble stores with little osmotic effect. Branching creates more chain ends for enzymes to remove glucose.

A plant can transport sucrose in phloem but store glucose units as starch. A liver cell stores glycogen so it can release glucose rapidly between meals without filling the cytoplasm with many separate sugar molecules.

Do not treat every polysaccharide as a fuel store: cellulose is also a glucose polymer, but its structure makes it a strong fibre rather than a readily digested reserve.

Benedict's reagent tests for reducing sugars: on heating, a blue solution changes through green, yellow and orange towards a brick-red precipitate as more copper(II) is reduced. Iodine solution turns blue-black when starch is present.

Use equal sample volumes, add the same reagent volume, heat Benedict's samples in a water bath for the same time, and include a water control. Compare the colour with a calibration series if estimating concentration.

A sample that stays blue in Benedict's but turns blue-black with iodine contains starch but no detectable reducing sugar under those conditions. Hydrolysing a non-reducing sugar first can reveal reducing products.

The colour is evidence of a chemical reaction, not a direct count of molecules. A semi-quantitative result is stronger when controls, repeats and a reference colour scale are used.

A negative Benedict's test means ‘not detected at this sensitivity’, not ‘no carbohydrate’. Heating, reagent volumes and subjective colour matching affect the conclusion.

A condensation reaction joins two monosaccharides while releasing water. The new covalent link is a glycosidic bond; hydrolysis adds water to break that bond and release smaller sugars.

The bond name records the carbon positions involved. For example, maltose has a 1,4 glycosidic bond between two glucose molecules, while sucrose joins glucose and fructose through a 1,2 link.

The same monomers can make molecules with different properties because bond position and orientation change branching, shape and enzyme access. Hydrolysis is therefore a controlled way to release absorbable sugars.

Digestive enzymes hydrolyse a disaccharide into monosaccharides before absorption. In a plant, repeated condensation builds a polysaccharide store and releases water at each bond formed.

Condensation forms the bond; hydrolysis breaks it. Do not say that a glycosidic bond is ‘a sugar molecule’ or assume all glucose polymers have the same structure.

A triglyceride forms when glycerol reacts with three fatty acids in condensation reactions, creating three ester bonds and releasing three water molecules. Its hydrocarbon tails store substantial chemical energy.

A saturated fatty acid has no carbon–carbon double bond; an unsaturated fatty acid has one or more. Double bonds introduce bends, so unsaturated tails usually pack less tightly and have lower melting points.

Long reduced hydrocarbon chains contain many bonds that can be oxidised, giving lipids a high energy value per gram. Their insolubility also makes them compact stores with little osmotic effect.

A fat rich in saturated tails tends to be solid at room temperature, whereas an oil rich in cis-unsaturated tails is more likely to remain liquid. The physical state reflects tail packing, not simply the word ‘lipid’.

One double bond does not make a lipid ‘healthy’ or determine every biological effect. Separate molecular structure, physical state and health evidence.

Diffusion is effective over short distances but becomes too slow when an organism is large or metabolically active. A circulatory system moves substances in bulk between exchange surfaces and tissues.

A pump maintains a pressure gradient and vessels provide a controlled route. The heart sends deoxygenated blood to the lungs and oxygenated blood to body tissues in a double circulation, keeping exchange gradients steep.

An active muscle has a high oxygen demand. Blood flow delivers oxygenated blood close to the cells and removes carbon dioxide, while diffusion completes the final short distance across capillary walls and tissue fluid.

The circulatory system does not replace diffusion: gases and solutes still cross exchange surfaces by diffusion or transport processes. Its role is to shorten effective transport distances and refresh gradients.

Arteries carry blood away from the heart under high pressure; veins return it at lower pressure; capillaries bring blood close to cells. The wall and lumen of each vessel suit its job.

Arteries have thick elastic and muscular walls to withstand and smooth pressure pulses. Veins have thinner walls, a wider lumen and valves to prevent backflow. Capillaries have a one-cell-thick wall and narrow lumen, slowing cells so exchange distances stay short.

A pulse can be felt in an artery because ventricular pressure stretches its elastic wall. A leg vein relies on valves and skeletal-muscle contractions to move blood back towards the heart against gravity.

Capillary branching creates a large exchange area; slow flow and a thin barrier allow oxygen, glucose and wastes to diffuse between blood and tissue fluid.

Arteries and veins are named by direction relative to the heart, not by oxygen content: the pulmonary artery carries deoxygenated blood and the pulmonary vein carries oxygenated blood.

One cardiac cycle alternates atrial systole, ventricular systole and diastole. Pressure changes caused by contraction and relaxation open or close valves, so blood moves in one direction.

During atrial systole, atria push blood into relaxed ventricles. During ventricular systole, atrioventricular valves close and semilunar valves open as ventricular pressure rises. During diastole, ventricles relax and refill when their pressure falls.

If ventricular pressure becomes greater than atrial pressure, the atrioventricular valve closes; if it becomes greater than arterial pressure, the semilunar valve opens. Valve movement follows pressure, not a separate command.

The sequence keeps oxygen-poor and oxygen-rich blood in the correct circuits and gives the heart time to fill between contractions.

Systole means contraction and diastole means relaxation; do not label a phase only by whether blood is entering or leaving, because pressure and valve state determine the flow.

Haemoglobin is a globular protein with four subunits, each able to bind oxygen reversibly. The percentage saturation curve is sigmoid because binding at one site affects the affinity of the remaining sites.

In the lungs, high oxygen partial pressure loads haemoglobin. In respiring tissues, lower oxygen pressure and higher carbon dioxide promote unloading, so oxygen is delivered where demand is greatest.

A working muscle produces more carbon dioxide and heat. The dissociation curve shifts right, meaning haemoglobin reaches a lower saturation at the same oxygen pressure and releases more oxygen.

The Bohr effect links carbon dioxide to oxygen delivery: carbon dioxide forms carbonic acid, lowering pH and reducing haemoglobin affinity. Foetal haemoglobin has a different affinity so oxygen can move from maternal blood to the foetus.

A right shift does not mean the blood contains no oxygen; it means affinity is lower at a given pressure. Read the curve and state the condition before inferring loading or unloading.

Atherosclerosis begins when the arterial endothelium is damaged. An inflammatory response attracts white blood cells, cholesterol-rich deposits and smooth-muscle changes, forming an atheroma in the artery wall.

Endothelial damage → inflammation → low-density lipoprotein enters the wall → macrophages form foam cells → plaque grows and narrows the lumen. A rough plaque can also encourage clot formation.

If a coronary artery lumen narrows, resistance to blood flow rises and cardiac muscle receives less oxygen. A plaque that ruptures may trigger a thrombus that blocks flow suddenly.

The disease links risk factors to a mechanism: high blood pressure can damage the endothelium, while smoking, diabetes and high LDL increase the likelihood of plaque development.

A risk factor raises probability rather than guaranteeing disease. Atherosclerosis is plaque formation in the artery wall; thrombosis is a clotting event that may follow it.

Damage to a blood vessel releases thromboplastin. In the presence of calcium ions, it helps convert soluble prothrombin into thrombin; thrombin converts soluble fibrinogen into insoluble fibrin.

Thrombin activates more clotting reactions and fibrin fibres form a mesh across the wound. Platelets become trapped, the mesh contracts and a clot reduces blood loss while tissue repair begins.

A cut exposes tissue and activates the cascade locally. The resulting fibrin network stays near the damaged vessel rather than turning all circulating fibrinogen into a body-wide clot.

The cascade amplifies a small trigger, but inhibitors and the intact endothelium limit clotting to the injury. If a clot forms inside an artery it can obstruct blood flow and cause thrombosis.

Prothrombin and fibrinogen are soluble plasma proteins; thrombin and fibrin are the active enzyme/product in the sequence. Do not reverse these pairs.

A risk factor is a characteristic associated with a higher probability of cardiovascular disease. Genetics, age, smoking, inactivity, diet and high blood pressure can alter risk, but none alone proves that an individual will develop disease.

Risk-factor data compare groups or exposures, often using relative risk or correlation. Confounding variables, sample selection and reverse causation can make a simple association misleading.

If smokers show a higher CVD rate than non-smokers, the result supports an association. To argue for causation, ask whether dose, timing, plausible mechanism and alternative explanations have been addressed.

Separate modifiable factors such as smoking and inactivity from non-modifiable factors such as age or inherited susceptibility. A prevention decision should weigh effect size, evidence quality and feasibility.

‘Causes’ is stronger than ‘is associated with’. A population trend does not predict an individual outcome, and reducing one risk factor does not remove every other source of risk.

Antioxidants can react with reactive molecules and may reduce oxidative damage. This gives a plausible link between diet and cardiovascular disease, but plausibility is not the same as demonstrated protection.

Oxidative damage can affect lipids and the arterial endothelium, yet CVD is also shaped by blood pressure, LDL, smoking, diabetes and activity. A single nutrient cannot be treated as an isolated cause.

A study may find that people who eat more fruit have lower CVD risk. The result could reflect antioxidants, fibre, lower saturated-fat intake or other lifestyle differences, so the design must address confounding.

Prefer evidence from controlled interventions or well-adjusted longitudinal studies over a single correlation. Report the strength and limits of the evidence before recommending a behaviour.

“Contains antioxidants” does not prove a food prevents CVD, and a supplement trial is not automatically equivalent to a whole-diet effect. Separate mechanism, association and outcome evidence.

To estimate vitamin C in a drink, use a reagent whose colour change is linked to the amount of vitamin C present, then compare the sample with standards or a measured titre. The endpoint must be defined before comparing samples.

Prepare a known vitamin-C standard series, keep reagent volume and sample volume consistent, test an unknown sample, repeat measurements and use the calibration relationship to estimate concentration. Protect vitamin C from unnecessary heat and oxidation.

A darker or later endpoint is only meaningful when the same conditions and endpoint rule were used. Replicates reveal random variation; a blank identifies colour from the drink rather than vitamin C.

If an orange drink decolourises more reagent than the diluted standard, first check dilution and endpoint consistency before concluding that it contains more vitamin C.

The practical estimates vitamin-C-equivalent reducing capacity under the chosen conditions; it does not prove that every antioxidant in the drink or its health effect has been measured.

Describe what the data show before explaining it: identify the population, units, trend and comparison. A correlation means two variables change together; it does not by itself show that one causes the disease.

Confounders such as age, income, activity or access to healthcare can influence both the risk factor and the outcome. Relative risk, absolute risk and sample size answer different questions.

If disease prevalence rises with smoking exposure, state the size and direction of the association, then ask whether dose, timing, biological mechanism and alternative explanations support a causal interpretation.

Use confidence intervals or statistical tests where supplied, avoid extrapolating beyond the population studied, and distinguish an individual prediction from a population estimate.

A statistically significant association can still be biased; a non-significant result does not prove no effect. “Linked to” and “causes” are not interchangeable.

Judge a study by asking who was sampled, how exposure and outcome were measured, whether comparison groups are appropriate, and whether the time sequence can support the claim. A large sample cannot rescue a biased design.

Check representativeness and sample size; define variables consistently; control or stratify confounders; use blinding or randomisation where possible; and report drop-outs and measurement uncertainty.

A questionnaire finding that diet and CVD are associated may suffer recall bias and self-selection. A prospective cohort with repeated measurements gives stronger temporal evidence but still cannot control every confounder.

Validity concerns whether the design supports the intended inference; reliability concerns consistency. Ethical limits may make a randomised exposure impossible, so conclusions should match the design.

An observational study can support an association without proving causation. Do not treat “peer reviewed” or “statistically significant” as substitutes for examining the method.

People often judge risk using vividness, familiarity and perceived control rather than the measured probability alone. Rare dramatic events can feel more likely than common gradual hazards.

Actual risk is estimated from population data and an agreed time frame; perceived risk is an individual judgement that can be shifted by media coverage, personal experience and trust in the source.

A person may fear a rare treatment side effect after seeing a news story but underestimate the cumulative CVD risk of smoking because it is familiar. The decision changes when absolute risk and comparison groups are made explicit.

Good communication does not simply replace perception with a number: it explains denominator, time horizon, uncertainty and the action that can change risk.

A perception is not “wrong” merely because it differs from an average statistic; context and values matter. But a decision should not confuse emotional salience with measured probability.

Cholesterol is transported in the blood in lipoproteins. LDL carries cholesterol towards tissues and is associated with atheroma risk when present in excess; HDL participates in reverse transport towards the liver.

A measured concentration is one risk indicator among many. Age, blood pressure, smoking, diabetes, genetics and treatment all affect the probability of CVD, and the relationship is population-based rather than deterministic.

Two people with the same LDL concentration can have different overall risk because their blood pressure, smoking status and family history differ. A treatment decision therefore uses a risk profile, not one number alone.

When interpreting data, identify the population, units, time period and whether the result is correlation or an intervention effect. Check uncertainty before claiming that changing one lipoprotein will remove risk.

HDL is not a guarantee of protection and LDL is not a diagnosis by itself. Avoid turning a continuous risk relationship into a binary label.

Reducing coronary heart disease (CHD) risk combines biological knowledge with an evidence-based decision: improve diet and activity, avoid smoking, manage blood pressure and interpret body-composition measures in context.

Body mass index and waist-to-hip ratio are screening indicators, not complete diagnoses. They can help identify groups for further assessment, but muscle mass, age, sex and ethnicity affect their meaning.

A high BMI may reflect muscle rather than excess adipose tissue; a central fat pattern may still signal metabolic risk. A sensible conclusion uses the measurement with blood pressure, lipids, family history and activity data.

When comparing an intervention, check whether risk-factor changes are measured over a relevant time and whether the study controls confounding. Translate the evidence into a proportionate recommendation rather than a guarantee.

“Lowers risk” is not “prevents disease”. Population evidence supports probability changes, not certainty for one individual.

Antihypertensives lower blood pressure; statins reduce cholesterol synthesis and LDL concentration; anticoagulants reduce clotting; platelet inhibitors reduce platelet aggregation. Each changes a different part of CVD risk.

A statin addresses long-term plaque risk, whereas an anticoagulant is relevant when unwanted clot formation is a concern. Beta blockers, vasodilators and diuretics lower pressure through different mechanisms.

A patient with high blood pressure and a high LDL concentration may need a different combination from a patient with an existing thrombus. Treatment choice depends on indication, benefit, contraindication and monitoring.

The same disease label can involve atherosclerosis, thrombosis or both. Matching mechanism to pathology prevents treating every cardiovascular problem as simply “high cholesterol”.

A drug reducing one risk factor does not erase all CVD risk, and benefits must be weighed against adverse effects. Do not infer a treatment recommendation from one measurement alone.

A gas-exchange surface is effective when it has a large area, a short diffusion distance and a steep concentration gradient. Fick’s law summarises this as rate ∝ surface area × concentration difference ÷ barrier thickness.

Alveoli provide a huge folded surface, a thin moist epithelium and a dense capillary network. Ventilation refreshes alveolar air and blood flow removes oxygen, maintaining the gradient.

If surface area doubles while thickness and gradient stay constant, the predicted diffusion rate doubles. If mucus thickens the barrier, diffusion slows even if oxygen concentration outside remains unchanged.

Small organisms can rely on their body surface because their surface-area-to-volume ratio is high. Larger organisms need specialised surfaces and transport systems to keep internal cells within diffusion distance.

Fick’s law is a proportional model, not a promise that every biological change is linear. Permeability, binding and active regulation can also limit transfer.

A cell-surface membrane is a phospholipid bilayer with hydrophilic phosphate heads facing water and hydrophobic fatty-acid tails facing inward. Proteins, cholesterol and carbohydrate chains give the membrane a fluid but selective structure.

Small non-polar molecules can diffuse through the hydrophobic core; ions and larger polar molecules require channel or carrier proteins. Cholesterol helps limit excessive fluidity and permeability.

Oxygen can cross the bilayer down its concentration gradient, whereas a charged sodium ion needs a membrane protein. A receptor protein can also convert an external signal into a cell response.

When explaining movement, identify the substance, its gradient, the membrane barrier and the protein or energy requirement. “Partially permeable” describes selectivity, not an absolute gate for every molecule.

The membrane is not a rigid wall and not an open sieve. Protein number, temperature and lipid composition can change the observed rate.

A permeability experiment uses a measurable proxy for material crossing a membrane, such as pigment leaking from beetroot cells. The proxy is not the membrane itself; it is evidence that membrane integrity or permeability changed.

Cut equal tissue pieces, rinse away surface pigment, place them in controlled volumes at different temperatures or treatments, and measure colour intensity with a colorimeter after the same time.

A colorimeter converts absorbance into comparable data, while repeats and a blank reduce random and background effects. Control tissue size, surface area, solvent volume and time so the tested variable is isolated.

If hotter water causes greater pigment absorbance, infer that membrane permeability increased under that condition. Do not infer a precise molecular pore size from colour alone.

The conclusion concerns the chosen tissue, treatment and proxy. It does not automatically generalise to every membrane or prove that all cell contents escaped.

Osmosis is the net movement of water across a partially permeable membrane from higher water potential to lower water potential. Water potential combines pressure effects and solute effects, so it is not simply “water concentration”.

A concentrated solution has a more negative solute potential. Water leaves a cell placed in a lower-water-potential solution, reducing turgor; water enters when the external solution has higher water potential.

If potato cylinders lose mass in a sucrose solution, the solution had a lower water potential than the potato cells. The concentration at which there is no net mass change estimates the tissue’s initial water potential.

Use equal cylinders, blot them consistently, control time and temperature, repeat at several concentrations and plot percentage mass change rather than relying on one sample.

Water still moves in both directions at the microscopic level; “no net movement” means equal opposing fluxes. Do not equate a mass change directly with solute entering the cells.

Simple diffusion moves small suitable molecules through the bilayer down a concentration gradient. Facilitated diffusion uses a channel or carrier but still moves down the gradient; active transport uses energy to move a substance against its electrochemical gradient.

Channels provide a hydrophilic route and can be gated. Carrier proteins bind a solute and change shape. Pumps use ATP directly or couple movement to another gradient.

Glucose may enter a cell through a carrier down its gradient, while a sodium–potassium pump uses ATP to maintain ion gradients that support nerve and epithelial transport.

The mechanism predicts sensitivity: diffusion depends on gradient and permeability; active transport depends on ATP supply, pump density and the gradient being maintained.

A membrane protein does not automatically imply active transport. State the direction, energy source and coupling before assigning the mechanism.

Amino acids share an amino group, carboxyl group and variable R group. Peptide bonds join amino acids by condensation to form a polypeptide; its sequence is the primary structure.

Hydrogen bonds, ionic interactions, disulfide bonds and hydrophobic interactions fold the chain into secondary, tertiary and sometimes quaternary structure. Shape determines binding and function.

Replacing one amino acid can alter charge or hydrophobicity, changing folding and a protein’s activity. A denatured enzyme may keep its peptide bonds but lose the shape of its active site.

Fibrous proteins form long structural arrangements; globular proteins fold into compact shapes with functional sites. Both depend on the same chemical principle that sequence constrains folding.

Primary structure is the amino-acid sequence, not the gene itself. A change in DNA can affect a protein, but environment and folding conditions also influence the final phenotype.

An enzyme is a globular protein whose tertiary structure creates a specific active site. A substrate binds by complementary shape and chemical interactions, forming an enzyme–substrate complex that lowers activation energy.

The induced-fit idea explains why binding can alter the active site slightly and position reactants for reaction. Temperature, pH and inhibitors can change the active site or block it, changing rate without changing the substrate itself.

If an enzyme’s active site loses its shape at extreme pH, the substrate concentration may remain high but fewer productive complexes form. A competitive inhibitor lowers the chance that substrate occupies the site.

Explain a rate change through collision frequency, active-site occupancy and protein structure. Distinguish denaturation from reversible inhibition when the conditions allow recovery.

The “lock and key” picture is a useful starting model, not a claim that the enzyme is rigid. Specificity does not mean an enzyme works at only one temperature or pH.

To investigate temperature, pH, enzyme concentration or substrate concentration, measure the initial rate of an enzyme reaction while changing one independent variable and controlling the others.

Use equal volumes, a defined mixing time and a signal that changes predictably, such as colour, gas volume or product concentration. Take several early readings, calculate a gradient and repeat at each condition.

Initial rate avoids later distortion when substrate is depleted or product accumulates. A water bath, buffer and matched enzyme volumes make the comparison fair.

A rate–temperature curve rises while collisions become more frequent, reaches an optimum and falls when the protein begins to lose structure. A plateau with increasing substrate may indicate that active sites are saturated.

A final colour or total gas volume is not automatically a rate. State the proxy, time interval, controls and uncertainty before interpreting the pattern.

A nucleotide contains a pentose sugar, phosphate group and nitrogenous base. DNA nucleotides contain deoxyribose and A, T, C or G; RNA nucleotides contain ribose and A, U, C or G.

Nucleotides join by phosphodiester bonds between the phosphate and sugars, forming a sugar–phosphate backbone. Complementary bases pair through hydrogen bonds: A with T in DNA or U in RNA, and C with G.

The base sequence stores information while the backbone gives the polymer continuity. The 2′ hydroxyl in ribose makes RNA chemically less stable than DNA and suits its shorter-lived information-carrying roles.

A DNA template with the base A pairs with a T in the complementary strand; an RNA transcript uses U instead. Replacing T with U is a molecule-level difference, not a change in the genetic message by itself.

A nucleotide is not just a base, and DNA/RNA strands are not held together by phosphodiester bonds between strands. Keep covalent backbone links separate from hydrogen-bonded base pairing.

Before cell division, DNA strands separate and each acts as a template. Free nucleotides pair by complementarity, DNA polymerase joins them into new strands, and each daughter DNA molecule contains one original and one new strand.

Helicase separates the strands; complementary nucleotides align; DNA polymerase forms phosphodiester bonds in the new strand. The two molecules then carry the same base sequence, apart from copying errors.

Meselson and Stahl grew bacteria with heavy nitrogen, moved them to light nitrogen and separated DNA by density. An intermediate-density band after one generation supported semi-conservative replication; later generations produced light and intermediate DNA.

The density pattern distinguishes semi-conservative replication from conservative and dispersive alternatives because it tracks old and newly synthesised DNA together.

DNA polymerase adds nucleotides to a template; it does not “copy a whole chromosome” in one step. Experimental evidence supports a model under stated conditions, not a claim that mutations never occur.

The genetic code is a triplet code: each three-base codon specifies one amino acid or a start/stop signal. Codons are read sequentially and non-overlapping on mRNA.

There are more codons than amino acids, so the code is degenerate: several codons can specify the same amino acid. This can make some substitutions silent but does not make every mutation harmless.

Changing a base in a codon may leave the amino acid unchanged, replace it with another, or create a stop codon. The outcome depends on the codon and on where it occurs in the coding sequence.

Translate from the correct start codon in the correct reading frame, then stop at a stop codon. A one-base insertion can shift every downstream triplet.

“Universal” means broadly shared across organisms, not that every codon has multiple meanings. Triplets are read on mRNA during translation, not as overlapping DNA words.

A gene is a sequence of DNA bases that contains information used to produce a functional polypeptide or RNA. The base sequence is transcribed and, for a protein-coding gene, translated into an amino-acid sequence.

The sequence determines codons, codons determine amino acids and the polypeptide folds into a functional shape. Regulatory sequences and expression level also affect when and where the product is made.

A mutation in a gene can alter one codon, introduce a stop signal or shift the reading frame. The phenotype changes only if the resulting product or its expression changes the relevant pathway.

A gene is not the same as a chromosome, allele or protein: a chromosome contains many genes, an allele is one version of a gene and a protein is a possible product.

Do not infer that every DNA difference changes phenotype. Degeneracy, non-coding changes, regulation and environmental conditions can all weaken a direct gene-to-trait claim.

Protein synthesis has two linked stages: transcription copies a gene into mRNA, then translation reads the mRNA to assemble a polypeptide. The DNA template (antisense) strand is used for transcription; codons are read on mRNA and anticodons pair on tRNA.

During transcription, RNA polymerase opens the DNA locally and joins complementary RNA nucleotides. The mRNA leaves the nucleus and binds to a ribosome. In translation, tRNA brings amino acids whose anticodons match successive mRNA codons; peptide bonds join the chain from the start codon until a stop codon.

A template triplet TAC produces an mRNA codon AUG. The ribosome recognises AUG as the start signal and the matching tRNA brings methionine; later codons determine the rest of the sequence.

RNA polymerase makes RNA during transcription; DNA polymerase is used in DNA replication. The mRNA sequence matches the coding strand except that RNA uses U instead of T.

A mutation is a change in a DNA base sequence. Its effect depends on the kind of change and on how that altered sequence is translated into a polypeptide; many mutations have little or no observable effect.

Insertion or deletion usually shifts the reading frame, changing every downstream triplet. A substitution changes one base triplet and may be silent, missense or nonsense. Duplication can provide an extra gene copy, while inversion reverses a DNA segment.

A one-base insertion before the second codon changes all later triplets and can produce a non-functional protein. A substitution may instead leave the amino acid unchanged because the genetic code is degenerate, or create a premature stop codon.

A mutation is not automatically harmful, and a changed amino acid is not automatically fatal. The consequence depends on the codon, the protein region, expression and the resulting phenotype.

A gene occupies a locus and its alternative forms are alleles. An individual's genotype is the allele combination; the phenotype is the observable result. Homozygous means two matching alleles, heterozygous means two different alleles, and dominance describes expression in a heterozygote—not importance.

For a monohybrid cross, write parental genotypes, list the alleles in their gametes, combine them in a Punnett square and convert genotypes to phenotypes. Pedigrees use symbols and family links to infer possible genotypes and whether an allele is likely dominant or recessive.

For Bb × Bb, the predicted genotypes are 1 BB : 2 Bb : 1 bb and, with complete dominance, phenotypes are 3 dominant : 1 recessive. Those are probabilities across many offspring, not a guarantee for four births.

Codominance or incomplete dominance changes the phenotype rule; sex-linked alleles require the X/Y chromosome context. Do not infer a person's exact genotype when the pedigree only supports several possibilities.

Cystic fibrosis is caused by recessive CFTR alleles that produce faulty chloride ion channels. Reduced chloride transport changes water movement by osmosis, making mucus unusually thick in several body systems.

In the airways, sticky mucus is harder for cilia to clear, so infection risk rises and blocked airways reduce gas exchange. In the digestive system, mucus can block pancreatic ducts and hinder enzyme delivery and nutrient absorption. In the reproductive system, thick mucus can obstruct sperm movement or passage.

Two unaffected carrier parents can each pass the recessive allele: the child-risk calculation is 1/4 affected, 1/2 carrier and 1/4 non-carrier. The inheritance probability and the physiological symptoms are linked but are not the same claim.

Not every CFTR mutation has an identical effect, and a recessive allele can be carried without symptoms. Explain the chain from gene to channel to water movement to system function rather than treating the disorder as only a lung disease.

Genetic screening tests DNA to identify a carrier, assess an embryo before implantation, or test a foetus during pregnancy. It informs a decision; it does not by itself predict every aspect of a person's future health.

Carrier testing checks an asymptomatic person's allele status. Pre-implantation genetic diagnosis analyses embryo cells during IVF before implantation. Prenatal testing uses chorionic villus sampling or amniocentesis to obtain foetal DNA during pregnancy.

Chorionic villus sampling is earlier than amniocentesis, while both can provide information about a familial disorder. A result may help parents prepare or consider options, but sampling carries procedure risks and tests can give false results.

Keep the test, the probability and the decision separate: a positive screen is not a guarantee of disease severity, and a negative result is not proof that no health problem exists. Genetic counselling helps interpret uncertainty.

The social and ethical question is not simply whether screening is possible, but how its information should be used. Judgements can concern autonomy, disability, privacy, fairness, pregnancy decisions and the interests of a future child.

Different viewpoints may weigh the same result differently: a family may value preparation or avoiding a severe disorder, while another may stress the risk of pressure, discrimination, unequal access or a narrow idea of which lives are worthwhile.

A carrier result can help a couple plan, yet sharing genetic data with insurers or employers could create harm. Prenatal or embryo results may support informed choice, but false positives, false negatives and procedure risks limit certainty.

An ethical discussion must identify whose values and evidence are involved rather than presenting one answer as scientifically forced. Screening information does not determine a person's worth or make a decision ethically automatic.